19-54220169-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_006864.4(LILRB3):c.1295C>T(p.Pro432Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000663 in 1,357,632 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 10/14 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_006864.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LILRB3 | NM_006864.4 | c.1295C>T | p.Pro432Leu | missense_variant | 7/13 | ENST00000445347.2 | NP_006855.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LILRB3 | ENST00000445347.2 | c.1295C>T | p.Pro432Leu | missense_variant | 7/13 | 2 | NM_006864.4 | ENSP00000388199.2 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 0AN: 142560Hom.: 0 Cov.: 19 FAILED QC
GnomAD4 exome AF: 0.00000663 AC: 9AN: 1357632Hom.: 0 Cov.: 35 AF XY: 0.0000119 AC XY: 8AN XY: 669850
GnomAD4 genome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 142560Hom.: 0 Cov.: 19 AF XY: 0.00 AC XY: 0AN XY: 68986
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 04, 2024 | The c.1295C>T (p.P432L) alteration is located in exon 7 (coding exon 7) of the LILRB3 gene. This alteration results from a C to T substitution at nucleotide position 1295, causing the proline (P) at amino acid position 432 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at